DR. PAUL CHANG, M.D.
Osteopathic Medicine at Morrison Way, Gardenville, PA
License number
Pennsylvania MD047959L
Category
Osteopathic Medicine
Type
Internal Medicine
Address
Address
3750 Morrison Way, Gardenville, PA 18902
Phone
(908) 745-8559
Personal information
See more information about PAUL CHANG at radaris.comName
Address
Phone
501 Winston Way, Berwyn, PA 19312
509 Hanley Ct, Warrington, PA 18976
366 Jefferson Ct, Trappe, PA 19426
3750 Morrison Way, Doylestown, PA 18902
2139 Hulmeville Rd, Bensalem, PA 19020
Organization information
See more information about PAUL CHANG at bizstanding.comPaul Chang MD
3750 Morrison Way, Doylestown, PA 18902
Industry:
Internist
Paul I-Chen Chang
Professional information
Vasopeptidase Inhibitors To Treat Isolated Systolic Hypertension
US Patent:
2002000, Jan 10, 2002
Filed:
Mar 28, 2001
Appl. No.:
09/819549
Inventors:
Richard Reeves - Pennington NJ, US
Robert Wolf - Newton PA, US
Paul Chang - Doylestown PA, US
Robert Wolf - Newton PA, US
Paul Chang - Doylestown PA, US
International Classification:
A61K031/55
US Classification:
514/212030
Abstract:
Vasopeptidase inhibitors, especially omapatrilat, are useful in treating isolated systolic hypertension. The vasopeptidase inhibitor may be used in combination with other pharmaceutically active agents.
Dr. Paul I Chang, Doylestown PA - MD (Doctor of Medicine)
Specialties:
Cardiology
Address:
3750 Morrison Way, Doylestown 18902
Certifications:
Cardiovascular Disease, 1991, Internal Medicine, 1989
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Yale University
The Ny Hosp
Yale New Haven Hospital
Yale University
The Ny Hosp
Yale New Haven Hospital
Method For Reducing Mortality With An Angiotensin Ii Antagonist
US Patent:
6201002, Mar 13, 2001
Filed:
Jan 6, 1998
Appl. No.:
9/003159
Inventors:
Polly A. Beere - Lahaska PA
Paul I. Chang - Doylestown PA
Bertram Pitt - Ann Arbor MI
Eva J. Rucinska - Blue Bell PA
Robert Segal - Gwynedd Valley PA
Divakar Sharma - Hatfield PA
Duane B. Snavely - Chalfont PA
Paul I. Chang - Doylestown PA
Bertram Pitt - Ann Arbor MI
Eva J. Rucinska - Blue Bell PA
Robert Segal - Gwynedd Valley PA
Divakar Sharma - Hatfield PA
Duane B. Snavely - Chalfont PA
Assignee:
Merck & Co., Inc. - Rahway NJ
International Classification:
A01N 4350
US Classification:
514397
Abstract:
Angiotensin II receptor antagonists are useful in reducing and preventing mortality and sudden cardiac death in symptomatic heart failure patients. Losartan potassium has been shown to reduce mortality and sudden cardiac death in this patient population. Additionally, losartan potassium has been shown to reduce the need for hospitalization of symptomatic heart failure patients.
Method For Treating Meniere's Disease
US Patent:
5817658, Oct 6, 1998
Filed:
Jun 24, 1997
Appl. No.:
8/881296
Inventors:
Peter K. S. Siegl - Blue Bell PA
Allan I. Goldberg - North Wales PA
Michael R. Goldberg - Plymouth Meeting PA
Paul I. Chang - Doylestown PA
Allan I. Goldberg - North Wales PA
Michael R. Goldberg - Plymouth Meeting PA
Paul I. Chang - Doylestown PA
Assignee:
Merck & Company, Inc. - Rahway NJ
International Classification:
A61K 3155
US Classification:
514221
Abstract:
A method for the treatment of Meniere's disease comprising the administration of a medicament which modulates the IKs channel of the ear and thereby reducing endolymph production.